Gene Therapy for Rare Disorders

Dedicated to Realizing the Commercial Potential of Gene Therapies.

Gene Therapy for Rare Disorders focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Incorporating insights from 50+ industry-leading speakers, this unique conference delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.

We are proud to announce that on March 27 at 2:00 pm our CEO, Ales Strancar, will have a presentation entitled "Industrial Purification Platform of AAV".